A. Hwang
Equibles does not estimate personal net worth.
Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.
Get PFE alertsAbout A. Hwang
The proxy statement of Pfizer Inc reports total compensation of $6,693,779 for A. Hwang in fiscal 2023, including a base salary of $1,340,450. Disclosed compensation is on record for 4 fiscal years. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.
Affiliation history
-
Pfizer Inc (PFE)
Proxy statement
Current
Company network
Leadership on record at Pfizer Inc
- A. Bourla CEO
- I. Read Chairman
- Cecile Guegan CFO
- D. Denton CFO
- David M. Denton CFO
- F. D’Amelio CFO
- Jennifer B. Damico Chief Accounting Officer
- James Quincey Board Member
- Susan Desmond-Hellmann Board Member
- Susan Hockfield Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Pfizer Inc (PFE) | Former Chief Commercial Officer and President, Global Biopharmaceuticals Business | $1,340,450 | $6,693,779 |
| 2022 | Pfizer Inc (PFE) | Former Chief Commercial Officer and President, Global Biopharmaceuticals Business | $1,276,500 | $9,746,368 |
| 2021 | Pfizer Inc (PFE) | Former Chief Commercial Officer and President, Global Biopharmaceuticals Business | $1,220,000 | $9,032,934 |
| 2020 | Pfizer Inc (PFE) | Chief Commercial Officer and President, Global Biopharmaceuticals Business | $1,142,500 | $7,883,447 |
Recent activity
No call appearances or filed executive changes recorded yet.